FDA Approves J&J’s Navistar ThermoCool For Atrial Fibrillation Ablation

With PMA approval Feb. 6, Johnson & Johnson/Biosense Webster's NaviStar ThermoCool and EZ Steer ThermoCool Navigational became the first cardiac ablation catheters approved by FDA specifically for treatment of atrial fibrillation

More from Archive

More from Medtech Insight